Balfaxar vs kcentra

BALFAXAR was found to be clinically non-inferior to Kcentra, resulting in early study termination at the prespecified interim analysis.1,2. Percentage of

List of Anticoagulant reversal agents ; Vitamin K1 phytonadione ; Mephyton phytonadione ; Praxbind idarucizumab ; Kcentra prothrombin complex ; Balfaxar

Balfaxar was effective in stopping bleeding in 94.6% of patients. By comparison, bleeding was stopped in 93.5% of patients treated with Kcentra.

78.1% of patients receiving BALFAXAR vs 71.8% in the Kcentra group had a reduction in INR to 1.5 at 30 minutes postinfusion in a randomized, controlled trial 1,c. Patients on BALFAXAR had sustained INR reduction to 1.3 for up to 24 hours after infusion1.

Balfaxar package insert / prescribing information for healthcare professionals. (n=105) or Kcentra (n=103). The doses of BALFAXAR and Kcentra based on the nominal

78.1% of patients receiving BALFAXAR vs 71.8% in the Kcentra group had a reduction in INR to 1.5 at 30 minutes postinfusion in a randomized, controlled trial 1,c. Patients on BALFAXAR had sustained INR reduction to 1.3 for up to 24 hours after infusion1.

List of Anticoagulant reversal agents ; Vitamin K1 phytonadione ; Mephyton phytonadione ; Praxbind idarucizumab ; Kcentra prothrombin complex ; Balfaxar

Clinical study for Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in

Brand names: Balfaxar, Beriplex, Confidex, Kcentra, Octaplex, Profilnine. References. ↑ Prothrombin Complex